Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Anthera Pharmaceutic (ANTH)

2.06 -0.07 (-3.29%)

11-22 16:00

Open:

2.15

Pre. Close:

2.13

High:

2.2094

Low:

1.96

Volume:

381,915

Market Cap:

29M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.25 - 2.28

2.28 - 2.33

Low:

1.87 - 1.89

1.89 - 1.94

Close:

2.01 - 2.06

2.06 - 2.14

Technical analysis  (as of: 2017-11-22 4:58:53 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 2.84     One year: 3.32

Support:

Support1: 1.76    Support2: 1.34

Resistance:

Resistance1: 2.43    Resistance2: 2.84

Pivot:

1.93

Moving Averages:

MA(5): 2.14     MA(20): 1.86

MA(100): 1.55     MA(250): 3.64

MACD:

MACD(12,26): 0.14     Signal(12,26,9): 0.12

%K %D:

%K(14,3): 62.32     %D(3): 67.27

RSI:

RSI(14): 59.94

52-Week:

High: 20.24  Low: 1.2  Change(%): -85.5

Average Vol(K):

3-Month: 58668  10-Days 87585

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ANTH has closed below upper band by 35.0%. Bollinger Bands are 117.7% wider than normal. The large width of the bands suggest high volatility as compared to ANTH's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Wed, 15 Nov 2017 13:07:30 GMT
Anthera Pharmaceuticals: Run Up Into Q1 Data

Fri, 17 Nov 2017 21:00:00 GMT
Anthera Pharmaceuticals Announces Receipt of Nasdaq Listing Determination ...

Tue, 08 Aug 2017 03:22:30 GMT
Anthera Pharmaceuticals: A Series Of Unfortunate Events

Thu, 09 Nov 2017 13:30:00 GMT
Anthera Pharmaceuticals Announces Completion of Recruitment in the Phase 3 ...

Tue, 05 Sep 2017 12:22:30 GMT
Anthera Looks To Redeem Itself After Failures

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

13.85

Shares Float (M)

8.58

% Held by Insiders

9.53

% Held by Institutions

29.16

Shares Short (K)

1370

Shares Short Prior Month (K)

1430

Stock Financials

EPS

-7.840

EPS Est. Current Year

-3.680

EPS Est. Next Year

-3.100

EPS Est. Next Quarter

-0.950

Forward EPS

-2.631

Book Value (p.s.)

0.400

PEG Ratio

-0.06

Profit Margin

Operating Margin

Return on Assets (ttm)

-139.4

Return on Equity (ttm)

-321.6

Qtrly Rev. Growth

Gross Profit (p.s.)

0.010

Sales Per Share

EBITDA (p.s.)

-3.619

Qtrly Earnings Growth

Operating Cash Flow (M)

-51.33

Levered Free Cash Flow (M)

-32.46

FoxReading.com

Valuation

P/E

-0.26

P/E Growth Ratio

-0.03

P/BV

5.15

P/S

P/CF

-0.56

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2017-05-01

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.